Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026)
Planet 13 Holdings' (PLNH) quarterly Non-Current Deferred Tax Liability came in at $663317.0 in Q1 2026, down 46.15% year-on-year from $1.2 million in Q1 2025, and up 30.87% on a QoQ basis from $506836.0 in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $663317.0 in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 46.15% year-over-year to $663317.0 in Q1 2026; TTM through Mar 2026 was $663317.0, a 46.15% decrease from a year earlier, with the FY2025 full-year figure at $506836.0, down 69.87% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $663317.0, up from $506836.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for PLNH reached as high as $3.9 million in Q3 2024 and fell as low as $11504.0 in Q3 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $1.9 million across 5 years, with a median of $1.5 million in 2023.
- Across the five-year window, Non-Current Deferred Tax Liability surged 165.91% in 2024 and sank 99.71% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $1.5 million in 2022, then jumped by 136.12% to $3.5 million in 2023, then sank by 52.1% to $1.7 million in 2024, then sank by 69.87% to $506836.0 in 2025, then jumped by 30.87% to $663317.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $663317.0 in Q1 2026, $506836.0 in Q4 2025, and $11504.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 663,317.00 |
| Mar 31, 2026 | 663,317.00 |
| Dec 31, 2025 | 506,836.00 |
| Dec 31, 2025 | 506,836.00 |
| Sep 30, 2025 | 11,504.00 |
| Sep 30, 2025 | 11,504.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Dec 31, 2023 | 3.51 Mn |